Edwards Lifesciences Corporation (EW.MX)
| Previous close | 1,586.62 |
| Open | 1,586.62 |
| Volume |
| Day's range | 1,497.43 - 1,617.82 |
| 52-week range | 1,132.99 - 1,617.82 |
| Avg. volume | 177 |
ZacksBD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
Business WireFive-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical
Simply Wall St.Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
